10q10k10q10k.net
Revvity

RevvityRVTYEarnings & Financial Report

NYSE · Health Care · Health Care Equipment

Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines.

Top Holders

Holder% OwnedSharesChangeAs of
T. Rowe Price Investment Management, Inc.14.40%
17.8M
▲ +1.70pp2024-11-14
The Vanguard Group11.49%
14.2M
—2024-02-13
BlackRock, Inc.7.00%
8.7M
—2024-01-26
T. ROWE PRICE ASSOCIATES, INC.5.30%
6.5M
—2024-11-14
S.S. OR5.10%
6.3M
—2024-11-14
Select Equity Group, L.P.4.30%
5.2M
▼ -4.80pp2024-11-14
OF ABOVE PERSONS2.50%
3.1M
▼ -3.70pp2024-11-12

Insider Transactions

Net 90d: −$4.68M · buys $0 / sells $4.68M
Range:
Action:
Role:
InsiderRoleAction
2026-04-20Anita GonzalesVice President and CAOSell (open market)
80
$92.80$7.4K
2026-03-16Anita GonzalesPlease See RemarksGrant
1.6K
$0.00$0
2026-03-06Anita GonzalesPlease See RemarksGrant
1.7K
$0.00$0
2026-02-24Miriame VictorPlease See RemarksOption exercise
1.9K
$95.74$178.3K
2026-02-24Miriame VictorPlease See RemarksSell (open market)
1.9K
$97.13$180.9K
2026-02-23McMurry-Heath MichelleDirectorSell (open market)
600
$97.26$58.4K
2026-02-05Singh Prahlad R.Please See RemarksOption exercise
25.5K
$92.09$2.35M
2026-02-05Singh Prahlad R.Please See RemarksSell (open market)
1.3K
$99.02$129.4K
2026-02-05Singh Prahlad R.Please See RemarksSell (open market)
12.2K
$99.55$1.21M
2026-02-05Singh Prahlad R.Please See RemarksSell (open market)
7.9K
$100.63$793.5K
1–10 of 24
Page 1 / 3